Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Arnon Karni
41 years of experience
Clinic is certified :
Plasmapheresis in Israel typically costs from $2,200 to $3,400. The final price depends on the underlying condition, diagnostic depth, and clinic tier. Patients save around 53% compared to the US, where the average price is $6,000. Treatment is primarily available in major medical hubs like Tel Aviv.
Bookimed Expert Insight: Choosing a multidisciplinary center like Sourasky Medical Center (Ichilov) offers superior value. This JCI-accredited facility integrates plasmapheresis with specialized departments like neurology or hematology. Expert doctors like Amnon Mosek use these procedures for complex drug-resistant conditions. While a comprehensive diagnostic package typically runs about $7,900, it ensures a precise treatment plan from a world-top 10 hospital.
Why choose Israel for plasmapheresis?
Access advanced Plasmapheresis solutions in trusted clinics .
| Israel | Turkey | Austria | |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Plasmapheresis upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Plasmapheresis and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Plasmapheresis journey.
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Week 2
Week 3
Please note that each patient"s case is individual and the provided schedule is an approximate plan. The actual process may vary based on individual health conditions and the doctor"s advice.
As the leading global medical tourism platform, Bookimed.com takes huge responsibility before our clients — both patients and medical centers in Israel. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors in Israel with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results for Plasmapheresis.
We collect the opinions of Bookimed clients in Israel only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose for Plasmapheresis. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com in Israel, you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly for Plasmapheresis. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team in Israel. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value in Israel. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com in Israel, please feel free to contact us at marketing@bookimed.com.
Dr. Amnon specializes in plasmapheresis at Sourasky Medical Center (Ichilov), offering advanced treatments for complex conditions.
Dr. Pazit Beckerman is a nephrologist with over 24 years of clinical practice in Israel. She specializes in chronic kidney disease (CKD), acute kidney injury (AKI), hemodialysis and peritoneal dialysis, hypertension-related kidney disease, glomerular diseases and proteinuria, electrolyte disorders, and kidney involvement in systemic diseases.
She served as Acting Director in 2020, Deputy Director from 2018 to 2020, and Senior Physician in the Department of Nephrology at Sheba Medical Center. She also heads the Israeli Dialysis Registry.
Education and training: MD, Hebrew University–Hadassah. Nephrology residency, Hadassah. Fellowship in nephrology, Sheba Medical Center. Biomedical Computational Studies, Bar-Ilan University. Postdoctoral fellowship, University of Pennsylvania.
Her research focuses on AKI, immune-related kidney complications, and chronic kidney disease. She has authored many publications. She is a member of the American Society of Nephrology and a board member of the Israeli Society of Nephrology and Hypertension.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.